UK Medicines and Healthcare Regulatory Agency alert on X-ray c-arm damage to devices and their continued use:
This article was originally published in Clinica
Executive Summary
The UK's Medicines and Healthcare Regulatory Agency (MHRA) has issued an alert regarding the incidence of damage, continued use and subsequent failure of "various devices in cardiac catheterisation and interventional radiology laboratories", following collision with the c-arm of X-ray equipment. "Devices have been damaged by collision with the X-ray c-arm, but have remained in use and subsequently failed, causing injury," reported the MHRA on July 18. Earlier this month, the UK parliamentary committee of public accounts (CPA) issued a damning report on efforts to address device safety issues (see Clinica No 1214, pp 3 & 9).
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.